معرفی
John Wilson is an Associate Professor in the Department of Chemical and Biomolecular Engineering, with joint appointments in Biomedical Engineering and Pathology, Microbiology and Immunology at Vanderbilt University's School of Engineering. His research focuses on engineering molecularly defined materials to interrogate and modulate immune system responses for therapeutic applications. Key areas include cancer immunotherapy, nanoparticle-based vaccine delivery systems, and diabetes-related islet transplantation. Wilson earned his PhD in Bioengineering from Georgia Institute of Technology and completed postdoctoral training at the University of Washington.
Education includes a B.S. in Bioengineering from Oregon State University. His lab develops advanced polymer systems for intracellular delivery of antigens and immunomodulatory agents, with emphasis on overcoming biological barriers to enhance immune activation. Research outputs span materials science, immunology, and translational medicine, with a focus on translating engineered materials into clinical applications.
Research interests are structured around four pillars: molecularly engineered biomaterials, intracellular delivery systems, vaccine colloids, and targeted cancer therapies. His work integrates polymer chemistry, drug delivery, and immunological principles to address unmet medical needs. The Wilson Laboratory’s innovations include pH-responsive nanoparticles for dual-delivery of tumor antigens and adjuvants, and scalable production of tissue-specific extracellular vesicles for immunomodulation.
